For effective healthcare and prevention of disease collaboration between health experts, policymakers and practitioners is crucial globally. We are continuing our work on global public health in two meetings during June, firstly focusing on viral hepatitis in Asia (being held in Hong Kong) and secondly tackling antimicrobial resistance in middle and low-income countries. We hope our discussion will help facilitate more effective strategies for both of these global health challenges.
Both viral hepatitis and antimicrobial resistance have been increasingly seen as major global public health threats. In 2010, a World Health Assembly resolution recognised viral hepatitis as a global threat. The burden is strikingly pervasive in Asia, which is home to more than 75% of all individuals with Hepatitis B, and more than 60% of those infected with Hepatitis C, and causes more deaths in the region than HIV, TB and malaria combined.
Our meeting in Hong Kong will help identify and overcome the key barriers to implementing effective hepatitis programming across the region. The previous meeting in this series focused on HIV co-infections in Asia.
Antimicrobial resistance also requires global collaboration for progress. The independent review on Tackling drug resistant infections globally, published on 19 May 2016, highlights the threats and offers 10 steps to reduce antibiotic demand and increase supply.
Recent resolutions agreed by the World Health Organization (WHO), Food and Agriculture Organization (FAO) and World Organisation for Animal Health (OIE) emphasised the severity of the global threat and called for countries to prepare National Action Plans (NAPs).
Our meeting will bring together policy leaders and other experts from 20 low and middle income countries responsible for setting up NAPs to discuss their progress in developing and implementing comprehensive plans, and the challenges and barriers they need to overcome.
The report from our AMR meeting in March 2015, focused on Ideas about how national actions to tackle AMR in low and middle income countries can be strengthened.